Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are effected
CA 2322848 A1 · Owner: Freedman, Steven · Inventors: Freedman, Steven; Alvarez, Juan G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating disorders in which DHA levels are affected is described. The method includes administering to a subject suffering from the disorder a therapeutically effective amount of DHA. This method is particularly useful in treating subjects suffering from a disorder characterized by a defect in the CF gene, e.g. cystic fibrosis, or a chronic inflammatory disorder e.g. ulcerative colitis, Crohn's disease chronic pancreatitis, asthma, rheumatoid arthritis or chronic gastritis. A method of ameliorating affects of cystic fibrosis in a newborn and a method of increasing surfactant levels in a fetus are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 3, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 3, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.